Literature DB >> 4026627

Value of multiple sclerosis diagnostic criteria. 70 autopsy-confirmed cases.

G Izquierdo, J J Hauw, O Lyon-Caen, R Marteau, R Escourolle, A Buge, P Castaigne, F Lhermitte.   

Abstract

We have evaluated the sensitivity of the most recent and most frequently used criteria for the diagnosis of definite multiple sclerosis by the retrospective study of the clinical files of 70 pathologically confirmed cases. For each case, the date of diagnosis was determined separately using different sets of criteria. The delay of diagnosis was then calculated. The diagnosis was made significantly earlier when certain criteria were used. This was more marked in the earlier years of the disease. We also found that cases of multiple sclerosis with progressive courses were diagnosed later than cases with other courses, whatever the criteria used. This was statistically significant only for a single criterion.

Entities:  

Mesh:

Year:  1985        PMID: 4026627     DOI: 10.1001/archneur.1985.04060080026010

Source DB:  PubMed          Journal:  Arch Neurol        ISSN: 0003-9942


  3 in total

Review 1.  Diagnostic Criteria, Classification and Treatment Goals in Multiple Sclerosis: The Chronicles of Time and Space.

Authors:  Achilles Ntranos; Fred Lublin
Journal:  Curr Neurol Neurosci Rep       Date:  2016-10       Impact factor: 5.081

2.  Application of the 2017 Revised McDonald Criteria for Multiple Sclerosis to Patients With a Typical Clinically Isolated Syndrome.

Authors:  Roos M van der Vuurst de Vries; Julia Y Mescheriakova; Yu Yi M Wong; Tessel F Runia; Naghmeh Jafari; Johnny P Samijn; Janet W K de Beukelaar; Beatrijs H A Wokke; Theodora A M Siepman; Rogier Q Hintzen
Journal:  JAMA Neurol       Date:  2018-11-01       Impact factor: 18.302

3.  Diagnostic value of paraclinical tests in multiple sclerosis: relative sensitivities and specificities for reclassification according to the Poser committee criteria.

Authors:  S Beer; K M Rösler; C W Hess
Journal:  J Neurol Neurosurg Psychiatry       Date:  1995-08       Impact factor: 10.154

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.